Broccoli Extract Powder Sulforaphane Bulk Supply

Broccoli Extract Powder Sulforaphane is a natural isothiocyanate compound extracted and purified from the seeds or young shoots of the cruciferous vegetable broccoli (Brassica oleracea L. var. italica). Sulforaphane is an active metabolite produced by the hydrolysis of glucoraphanin under the action of endogenous myrosinase, and is one of the most potent isothiocyanate compounds with anti-cancer activity found in cruciferous vegetables. Owing to its exceptional antioxidant capacity (achieved through activation of the Nuclear Factor E2-related factor 2 (Nrf2) pathway), anti-inflammatory activity, anti-cancer potential, and its role in managing various chronic diseases, sulforaphane holds significant application value across sectors, including dietary supplements, functional foods, pharmaceutical intermediates, sports nutrition, and premium skincare products.

This product is positioned for the global B2B bulk raw material supply market. As a source manufacturer, we specialise in providing professional-grade raw materials, characterised by high purity (HPLC 1%–10%, customisable), batch consistency, quality control, and supply chain traceability to buyers in the plant extract industry, product R&D teams, manufacturing facilities, and brand decision-makers. We hold international certifications, including ISO 9001, ISO 22000, HACCP, Kosher, and Halal, with an annual supply capacity exceeding 5,000 kg. We offer flexible sample support (minimum sample quantity of 50g) and aim to meet the end-to-end requirements of enterprise-level clients, from R&D testing to large-scale global production.

PS: This page focuses on the Integrated Supply Chain & Solutions.

For the product application information, please click Functional Food Ingredient Sulforaphane Powder SFN.

For the product Technical Data Sheet, please click Broccoli Extract Powder Sulforaphane HPLC5% 21414-41-5‌ TDS.

As a high-value bioactive compound extracted from broccoli, sulforaphane faces several critical industrial-scale conversion bottlenecks in its transition from laboratory research to large-scale commercial application. Gaining a thorough understanding of and resolving these bottlenecks is key to distinguishing between 'ordinary plant extracts' and 'high-value raw materials for commercial applications', and it is precisely where our value lies as a source manufacturer.

Challenge 1: Technical Barriers Regarding Precursor Conversion Efficiency and Active Ingredient Stability

Sulforaphane does not exist in a free form within plant tissues, but rather as its precursor, glucoraphanin. This precursor must be hydrolysed by the enzyme myrosinase to produce the active form of sulforaphane. This characteristic presents three key industrial challenges:

1. Process-dependent enzymatic conversion efficiency: Extracting sulforaphane from broccoli seeds requires not only effective extraction techniques but also precise control of enzymatic conditions to efficiently convert the precursor into its active form. Research indicates that the optimal reaction conditions for glucoraphaninase are 40°C and pH 7.0; under these conditions, glucoraphanin in broccoli seeds can be efficiently degraded, with a conversion efficiency of up to 92.48%. Differences in enzymatic processes between manufacturers directly result in significant variations in product yield, purity, and activity.
2. The inherent contradiction between molecular structure and chemical stability: The isothiocyanate groups in the molecular structure of sulforaphane confer high reactivity but also pose stability challenges. Research confirms that sulforaphane is highly unstable and thermosensitive, with its stability easily affected by factors such as temperature, pH, and light exposure. Under high-temperature, alkaline, or prolonged light exposure conditions, sulforaphane is prone to degradation, leading to a reduction in active ingredient content and diminished efficacy.
3. The non-linear relationship between purity and cost: Standard grades of sulforaphane include 1%, 5%, and 10%. Increasing purity from 1% to 10% involves advanced purification processes such as multi-stage chromatography and low-temperature concentration, placing higher demands on production equipment and technical expertise. The ability to consistently supply high-purity grades is a key indicator of a source manufacturer's technical capabilities.

For B2B clients, this implies that when procuring sulforaphane, the supplier's maturity of enzymatic hydrolysis processes, stability control during production, and batch-to-batch consistency of purity specifications are more critical decision-making factors than price alone. There may be a fundamental difference in the performance of products from a supplier capable of providing only crude extracts compared to a source manufacturer with advanced purification capabilities during subsequent formulation development.

Our scientific response and product solutions:

As a source manufacturer, we have established a comprehensive technical control system covering the entire supply chain from raw materials to finished products.

• Full-process inert gas protection: Nitrogen protection is employed throughout the entire process from extraction to drying, with production temperatures strictly controlled below 40°C. This minimises thermal degradation and oxidative losses during processing, ensuring the product's 'true purity' rather than merely its apparent purity'.
• HPLC dual-standard testing system: We not only provide data on the main component content but also control the spectra of key impurities, ensuring consistent purity of the main peak and reproducible impurity profiles across HPLC chromatograms of different batches.

Challenge 2: Bioavailability Bottlenecks and the Difficulty of Adapting Delivery Systems

Although sulforaphane exhibits exceptional in vitro activity, its bioavailability in vivo faces multiple constraints:

1. Limitations on oral absorption efficiency. Studies indicate that the oral bioavailability of sulforaphane is significantly influenced by factors such as the gastrointestinal environment, the composition of the gut microbiota, and individual metabolic differences. Sulforaphane is rapidly metabolised and excreted via the thiol-uric acid pathway, exhibiting characteristics of rapid metabolism and excretion.
2. Technical barriers associated with delivery systems: Recent research confirms that the use of microencapsulation technology can significantly improve the stability and bioavailability of sulforaphane. Following the microencapsulation of broccoli sulforaphane using whey protein, its in vitro bioavailability (67.7 ± 1.2%) and bioavailability (54.4 ± 4.0%) were both significantly higher than those of unencapsulated dried broccoli powder (19.6 ± 10.4% and 15.8 ± 2.2%). This indicates that whey protein isolate is a promising encapsulation material capable of protecting and stabilising sulforaphane to enhance its biological activity.
3. Individual variations dependent on gut microbiota: Glucoraphanin, the precursor of sulforaphane, can be metabolised by gut microbiota; differences in gut microbiota composition among individuals may lead to significant variations in sulforaphane production efficiency and in vivo exposure levels.

For B2B clients, this implies that the efficacy of sulforaphane cannot be simply validated using the linear assumption that 'in vitro activity equals in vivo efficacy'. A sulforaphane project with commercial potential requires end-to-end validation spanning the entire chain-from ingredient profile and delivery system to in vivo metabolism and target action-and must consider the optimal selection of delivery technologies.

Our scientific responses and product solutions:

• Delivery technology consultancy: To address bioavailability issues, we can recommend improvement strategies such as microencapsulation, cyclodextrin inclusion, and nanoemulsions, and can provide reference solutions based on whey protein encapsulation technology.
• Application data support: Drawing on industry experience, we can provide clients with stability data for sulforaphane in various formulation systems, as well as references regarding its compatibility with lipid and protein excipients.
• Support for Efficacy Research Literature: We can provide clients with basic research literature on sulforaphane and its precursors, including research data on its activation of the Nrf2 pathway, as well as its antioxidant, anti-inflammatory, anti-cancer, and neuroprotective properties, to support the accumulation of scientific claims.

As a manufacturer at the source, we have established a comprehensive quality assurance system and the capacity for immediate supply. Core Strengths are as follows:

• Quality under control: We have specialised in the research, development and production of plant extracts for over a decade, and operate an integrated production facility covering everything from the procurement of broccoli seeds to modern extraction, enzymatic hydrolysis and purification. Our annual production capacity for sulforaphane products exceeds 5,000 kg, enabling us to meet the diverse needs of global clients, ranging from small-batch R&D to large-scale mass production.

1. Batch Production Model:

Even for orders in the tonnes, we employ a multi-batch production strategy to ensure consistent product quality across every batch.

2. Annual Procurement Plan:

We support everything from 100 kg trial orders to annual orders in the tonnes, meeting the long-term needs of functional food companies.

3. Safety stock mechanism:

We maintain appropriate inventory levels to address urgent orders or transport delays, ensuring the smooth execution of production schedules.

• Comprehensive international certifications: Our production facilities strictly adhere to the ISO 9001 Quality Management System, ISO 22000 Food Safety Management System, and HACCP standards, with key production processes compliant with cGMP guidelines. We also hold international certifications such as Kosher and Halal, meeting the specific requirements of different markets and religious cultures.

• Exceptional Purity and Batch Consistency: Utilising proprietary low-temperature enzymatic hydrolysis and gradient purification processes, the core indicators of sulforaphane remain stable and controllable.
• Professional Technical Services: We are equipped with an application laboratory and a team of experienced technical consultants, enabling us to provide targeted application advice, specification recommendations, and stability testing support to clients during the early stages of formulation development.

Sample Service Policy

To ensure a smooth partnership for our clients, from initial contact through to long-term bulk procurement, we have established an industrial-grade supply chain process specifically for the bulk supply of Broccoli Extract Powder Sulforaphane:

1. Enquiry and Requirements Confirmation: Clients contact us via the website contact form or directly by email/telephone, providing details of the intended application, target specifications (1%/5%/10% or other), sample requirements and estimated usage.

2. Sample Provision and Technical Support: We respond to enquiries within 24 hours, dispatching samples and the corresponding batch Certificate of Analysis (COA) as required. For complex applications, we can initiate preliminary technical consultations.

3. Commercial Negotiations and Contract Signing: Based on purchase volume, packaging and logistics requirements, we provide competitive quotations and supply schedules. We accept various payment methods, including Telegraphic Transfer (T/T) and Letters of Credit (L/C).

4. Production Scheduling and Rigorous Quality Control: Once an order is confirmed, stock items are dispatched within 3–5 working days; production lead times for customised or bulk orders range from 2–4 weeks, with comprehensive quality inspections conducted before dispatch.

This process ensures that clients can complete long-term, large-scale, cross-border procurement projects through a single point of contact, thereby reducing supply risks and the risk of production disruptions.

To ensure the stability of the powder during transport and storage, the packaging system is designed as follows:

1. Inner packaging: Food-grade aluminium foil bags or PE bags, protecting against moisture, oxidation and light.
2. Outer packaging: Cardboard drums or fibre drums, suitable for palletised and containerised transport.
3. Standard specification: 25 kg per drum; customised packaging can be provided upon request for long-term customers.
4. Transport Compatibility: Tested for sea and air freight as well as long-term warehousing to ensure the stability of sulforaphane activity and the physical properties of the powder. Industrial packaging not only safeguards product quality but also enhances logistics efficiency and facilitates warehouse management, making it a vital component of the global supply chain.

Packaging Specifications:

• 1 kg/bag: Aluminium foil bag (lined with a food-grade sterile bag, vacuum-packed and nitrogen-flushed)
• 5 kg/bag: Aluminium foil bag, housed in an external moisture-proof cardboard drum
• 25 kg/drum: Cardboard drum or HDPE drum, lined with double-layer food-grade plastic bags.
• Customised packaging available upon request

Cross-border procurement demands high standards of logistics stability and compliance. Our logistics system is specifically designed for the bulk supply of Broccoli Extract Powder Sulforaphane:

• Trade Terms: FOB, CIF, CFR, DAP and DDP are all supported to meet the needs of different clients.
• Transportation Methods: Primarily sea freight, suitable for orders in tonnes; air freight for samples or urgent restocking; combined sea-air transport to flexibly address special market demands.
• Documentation Support: COA, SDS/MSDS, Certificate of Origin and product specifications to ensure smooth customs clearance.
• Logistics Risk Management: We provide transport insurance and end-to-end cargo tracking to mitigate the risks associated with international shipping. Logistics Services: We have established stable partnerships with international logistics giants such as DHL, FedEx and UPS to provide door-to-door delivery services. Refrigerated transport options are available for temperature-sensitive orders. Through our comprehensive logistics system, customers can obtain raw materials quickly and ensure the stability of their global supply chains.

Estimated delivery times:

Sample orders: 3–5 working days

Small-batch stock orders (<100kg): 3–7 days

Bulk orders by air freight: 5–8 days

Bulk orders by sea freight: 15–30 days (depending on destination)

Delivery and ongoing support: Full customs clearance documentation (commercial invoice, packing list, certificate of origin, COA, MSDS, etc.) is provided with the shipment, along with end-to-end logistics tracking. We continue to monitor customer usage after delivery and provide necessary follow-up technical support.

Q1: What is the difference between sulforaphane and the aqueous extract of broccoli seeds?

A1: Aqueous extract of broccoli seeds typically refers to a crude extract containing glucoraphanin, a precursor of sulforaphane, which requires the action of myrosinase or gut microbiota within the body to be converted into active sulforaphane. Sulforaphane, on the other hand, is an active monomeric compound obtained through enzymatic conversion and purification, and can exert its biological activity directly without requiring conversion within the body. The choice between the two depends on the application requirements: if a stable precursor is required to prolong the metabolic half-life in the body, glucoraphanin may be selected; if a direct active ingredient with a precise dose-response relationship is required, sulforaphane is recommended.

Q2: How stable is sulforaphane? How can its bioactivity be maintained in formulations?

A2: Sulforaphane is heat-sensitive and prone to degradation under high-temperature conditions.

Common strategies to improve stability include:

1) Encapsulation using microencapsulation technology; encapsulation with whey protein can significantly enhance bioavailability (67.7±1.2%);

2) Applying cyclodextrin inclusion technology;

3) Avoiding high-temperature processing in formulations (recommended <40°C);

We can provide stability data support and encapsulation technology consultancy tailored to different application scenarios.

Q3: How should one choose between different concentrations of sulforaphane, such as 1%, 5% and 10%?

A3: Different concentrations are suitable for different applications: the 1% concentration is suitable for cost-sensitive applications or for use as a base antioxidant in formulations; the 5% concentration strikes a balance between efficacy and cost, and is widely used in dietary supplements and functional foods; the 10% concentration is suitable for formulation systems requiring higher efficacy and precise dose-response relationships.

 Sulforaphane is one of the core, high-value ingredients in our line of cruciferous plant extracts. To assist you in developing more innovative and competitive end products, we recommend that you also consider the following products, which offer synergistic effects or are derived from related sources:

Visit our website (www.appchem.cn) to explore our complete catalogue of plant extracts and discover more specialised ingredient solutions.

Reference

[1] Kensler TW, Egner PA, Agyeman AS, Visvanathan K, Groopman JD, Chen JG, Chen TY, Fahey JW, Talalay P. Keap1-nrf2 signalling: a target for cancer prevention by sulforaphane. Top Curr Chem. 2013;329:163-77. doi: 10.1007/128_2012_339.

[2] Lewis KN, Mele J, Hayes JD, Buffenstein R. Nrf2, a guardian of healthspan and gatekeeper of species longevity. Integr Comp Biol. 2010 Nov;50(5):829-43. doi: 10.1093/icb/icq034. Epub 2010 May 6.

[3] Bai Y, Wang X, Zhao S, Ma C, Cui J, Zheng Y. Sulforaphane protects against cardiovascular disease via Nrf2 activation. Oxid Med Cell Longev. 2015;2015:407580. doi:10.1155/2015/407580

[4] Singh K, Connors SL, Macklin EA, et al. Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci U S A. 2014;111(43):15550-15555. doi:10.1073/pnas.1416940111

[5] Bent S, Lawton B, Warren T, et al. Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli. Mol Autism. 2018;9:35. doi:10.1186/s13229-018-0218-4

[6] Ou J, Smith RC, Tobe RH, et al. Efficacy of sulforaphane in treatment of children with autism spectrum disorder: a randomised double-blind placebo-controlled multi-centre trial. J Autism Dev Disord. 2024;54(2):628-641. doi: 10.1007/s10803-022-05784-9

[7] Nagata N, Xu L, Kohno S, et al. Glucoraphanin ameliorates obesity and insulin resistance through adipose tissue browning and reduction of metabolic endotoxemia in mice. Diabetes. 2017;66(5):1222-1236. doi:10.2337/db16-0662